Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 30+ AI models, with 0% extra fees
Teladoc Health stock price rises after aggressive investors apply pressure
Investing.com – Teladoc Health Inc. (NYSE:TDOC) shares rose 4% on Tuesday, after activist investors Pineal Capital Management urged the company to implement a stock buyback program and conduct a strategic review.
In a public letter dated March 31, Pineal Capital urged Teladoc to launch at least a $200 million stock repurchase program and consider splitting its two main business segments. The investment firm criticized Teladoc’s board for slow decision-making and poor capital allocation, including the 2020 acquisition of Livongo.
Pineal Capital noted that Teladoc’s current trading price is about 4.18 times the enterprise value-to-EBITDA multiple for 2026. The company emphasized that Teladoc’s share price has fallen by more than 90% from its pre-pandemic peak, while the number of basic shares outstanding increased from about 90 million in 2020 to 177 million in December 2025. According to the letter, the company has never conducted a stock buyback in its listing history.
Teladoc operates through two business segments: a comprehensive care business that provides services to employers and health plans, and the mental health platform BetterHelp. The company serves more than 100 million people, and in 2025, mental health-related revenue exceeded $1.1 billion.
Pineal Capital pointed to recent policy changes, including permanent coverage for virtual care under high-deductible health plans and the $50 billion Rural Health Transformation plan, as potential growth drivers. The company said that BetterHelp’s insurance-supported revenue annualized operating rate reached about $28 million by the end of 2025, and it expects the run-rate exit operating rate to reach $100 million in 2026.
The investment firm mentioned that the recent Talkspace acquisition price was 3.0 times revenue and 25 times EBITDA, whereas, based on market consensus expectations, Teladoc’s current valuation multiples are 0.47 times revenue and 4.18 times EBITDA.
Pineal Capital warned that Teladoc’s undervalued valuation makes it vulnerable to opportunistic acquisitions.
This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.